close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar192671Point75
Implied share price

Buy Undervalued by 246125.9%

5% margin of safety What's this?

EV / Revenue
Use Average
ABII
Abraxis Bioscience, Inc.
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
AGN
Allergan, Inc.
Change
WPI
Watson Pharmaceuticals, Inc.
Change
21713.92 8.25 27840.41 3.08 9.65 9.65
All amounts in millions
from last financial year
         
Implied Share Price $192671.75 $48724.34 $489128.25 $719615.75 $719615.75
Market Cap 3,166 1,229,412 125,901 110,544 110,544
Net Debt -203 20 -26,208 15,514 15,514
Enterprise Value (EV) 2,963 1,229,432 100,376 126,058 126,058
Revenue 359 44 32,639 13,062 13,062
Balance Sheet          
Total Assets 1,068 58 51,839 52,758 52,758
Total Liabilities 225 56 32,724 24,426 24,426
Shareholders Equity 842 2 19,115 28,331 28,331.1

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.